Updated:
JSR Life Sciences
JSR Life Sciences provides CDMO and CRO services via Crown Bioscience and KBI Biopharma, covering early-stage discovery to commercial biopharma production.
JSR Life Sciences
From Discovery to Commercialization, JSR Life Sciences is Empowering the Next Generation of Medicines Through Our CDMO, CRO Capabilities
General information
Firm type
Asset Manager
Location
Region
North America
Country
United States
City
Sunnyvale
Corporate office
Sunnyvale, CA, United States
Additional offices
Leuven, Belgium · Tokyo, Japan · San Diego, CA, United States · Portland, OR, United States · Seattle, WA, United States · Durham, NC, United States · Vancouver, Canada
Sector focus
Frequently asked questions
Who runs investment decisions at JSR Life Sciences?
JSR Life Sciences does not publicly name a CEO, CIO, or investment committee members. Leadership information is not available on its website or in public sources.
How does JSR Life Sciences source proprietary deal flow?
As a CDMO/CRO platform, JSR Life Sciences generates deal flow through biopharma client relationships. Crown Bioscience and KBI Biopharma each independently contract with drug developers. No proprietary sourcing model or investment fund is disclosed.
Is JSR Life Sciences structured as a single family office or does it operate more like a venture firm?
Neither. JSR Life Sciences is an operating subsidiary of JSR Corporation, a Japanese materials company. It does not function as a family office or venture capital firm. It provides fee-for-service contract research and manufacturing.
Does JSR Life Sciences participate in fund commitments or only direct deals?
JSR Life Sciences does not appear to participate in fund commitments. Its business model is direct service contracts with biopharma clients. No fund vehicles or co-investment structures are disclosed.
What investment stages does JSR Life Sciences typically target?
The firm covers early-stage discovery through commercial-scale manufacturing via its two subsidiaries and in-house products. This is a service lifecycle, not an investment stage.
Which sectors does JSR Life Sciences explicitly avoid?
The firm does not publicly state any excluded sectors. Its activities are limited to life sciences and biopharma services.
Where does the underlying wealth come from?
JSR Life Sciences is a subsidiary of JSR Corporation, a publicly traded Japanese company. No family wealth origin exists for this entity.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: